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ABSTRACT The degradation rates of several Dlissense 
Dlutants of hypoxanthine-guanine phosphoribosyltrans-
ferase (EC 2.4.2.8) in Dlouse L cells are coDlpared to those 
of the wild-type enZYDle. Although the rates of total pro-
tein breakdown in the Dlutant cell lines are identical to 
that of the parental L cell line, defective Dlolecules of 
hypoxanthine-guanine phosphoribosyltransferase present 
in the Dlutant cell lines are degraded Dluch faster than 
the wild-type enZYDle. The level of defective phosphoribo-
syltransferase Dlolecules present in the Dlutant cell lines 
is inversely proportional to the breakdown rate. This ob-
servation indicates that the Dlajor factor deterDlining the 
concentrations of the defective phosphoribosyltransferases 
is their specific degradation rate. These results strongly 
support the hypothesis that abnorDlal proteins are se-
lectively degraded ill DlaDlDlalian cells. 
Proteins in eukaryotic and prokaryotic cells are in a dynamic 
state, continuously being synthesized and degraded (1-3). 
To replenish the degraded proteins, the cell expends consider-
able metabolic energy. It is still unclear what underlying 
physiological advantage is conferred by continuous protein 
turnover. It may provide a means of preventing the accumula-
tion of abnormal and possibly deleterious proteins (1, 2). If 
the protein degradative machinery of the cell could selectively 
remove defective proteins, then the pool of abnormal proteins 
would be reduced relative to normal proteins. 
Abnormal proteins can arise in several ways. Proteins may 
age during the course of normal cellular functioning (4-6). 
Errors in protein synthesis at the transcriptional and transla-
tionallevel can generate abnormal proteins (7). Diploid cells 
may have the special requirement for eliminating abnormal 
proteins produced by recessive mutations in one of the two 
alleles. 
There are several observations in Escherichia coli and mam-
malian cells that are compatible with the hypothesis that pro-
teolytic degradation functions selectively to eliminate abnor-
mal proteins. Polypeptide fragments produced by deletions 
or nonsense mutations in E. coli are degraded more rapidly 
than the corresponding normal proteins (8-12). Bacterial 
strains that contain mutations causing increased errors in 
translation, such as RAM and missense suppressor mutations, 
exhibit increased rates of total protein breakdown (13). Cells 
that have incorporated certain amino acid analogues in vivo 
Abbreviations: HGPRT, hypoxanthine-guanine phosphoribosyl-
transferase; CRM, erossreacting material; NaDodSO., sodium 
dodecyl sulfate; phosphate-buffered saline, 137 mM NaCI, 2.7 
mM KCI, 8.1 mM Na2HPO, 1.5 mM KH2PO. (pH 7.5). 
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also have higher rates of total protein degradation (8, 13, 14). 
Indications that abnormal hemoglobins may be degraded 
faster have also been reported (15, 16). 
In this communication we examine the degradation rates of 
several missense mutants of hypoxanthine-guanine phosphori-
bosyltransferase (HGPRT, EC 2.4.2.8; IMP: pyrophosphate 
phosphoribosyltransferase) in mouse L cells. This system has 
a number of distinct advantages for studying the model of 
selective catabolism of abnormal proteins. First, under 
normal growth conditions HGPRT is a nonessential enzyme, 
so loss of the enzymatic activity does not perturb the physi-
ology of the cell. (This approach avoids the use of toxic 
agents such as amino-acid analogues or puromycin to induce 
the synthesis of abnormal proteins. Such agents may cause 
pleiotropic effects that could alter proteolytic rates.) Second, 
HGPRT is a minor component of the total protein pool (i.e., 
about 1/5000). Thus, large changes in the rate of degradation 
of HGPRT do not affect the total rate of proteolysis of the 
cell. Third, the mutants examined in this study have all lost 
enzymatic activity but retain their immunological reactivity 
with antiserum directed against purified wild-type HGPRT 
[Le., they are positive for crossreacting material (CRM+)] 
(17). With HGPRT, immunological reactivity is a fairly sensi-
tive criterion for structural integrity. For example, heating 
wild-type HGPRT inactivates the antigenic determinants 
and enzymatic activity at exactly the same rate (17). Since 
the mutant proteins are known to be structurally similar to 
wild type proteins, these experiments are a stringent test 
of the cells' ability to detect and selectively degrade abnormal 
proteins. . 
Although the total proteolytic rates in the mutant cell lines 
are identical to that of the parental cell line, the defective 
HGPRT molecules in the mutant cell lines are degraded faster 
than wild-type enzyme. The amount of mutant protein 
present in the cell is inversely proportional to its degradation 
rate. This observation indicates that selective proteolysis is 
the major factor determining the concentration of these 
abnormal proteins in the cell. 
MATERIALS AND METHODS 
Materials. The preparation and characterization of anti-
serum against HGPRT is described in ref. 17. Antibody 
against rabbit IgG prepared in goat was the generous gift of 
Dr. M. C. Rechsteiner. [3H]Leucine (50 Ci/mmol) and [3H]_ 
lysine (47 Ci/mmol) were purchased from Schwarz/Mann. 
[86S]Methionine (100 Ci;mmol) was obtained from New 
England Nuclear Corp. Triton X-IOO was a product of Rohm 
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and Haas Co., Independence Hall West, Philadelphia, Pa. 
DE-81 filter discs were purchased from Whatman. Acrylamide 
and N,N'-methylene bisacrylamide were obtained from East-
man Kodak. Ultrapure sodium dodecyl sulfate (NaDodS04) 
was purchased from Pierce Chemical Co., P. O. Box lA, 
Rockford, Ill. 
Cell Line and Culturing Methods. Wild-type L cells (L+) 
were obtained from J. Littlefield. The HGPRT- mouse L cell 
mutants examined in the present study were those derived by 
Sharp et al. (18). These mutants were selected for resistance to 
a combination of 8-azaguanine and 6-thioguanine after N-
methyl-N'-nitro-N-nitrosoguanidine mutagenesis. The me-
dium and conditions used for cell culture have been described 
(18). 
Cell Extracts were prepared in a 4° room with all buffers at 
0-40. The wild-type and mutant cell lines were harvested 
from monolayer cultures grown on 6O-mm plastic plates 
(Falcon). The plates were washed three times with 5 ml of cold 
phosphate-buffered saline [137 mM NaCI, 2.7 mM KCl, 8.1 
mM Na2HP04, 1.5 mM KH2P04 (pH 7.5)] and drained for 
about 5 min. One-quarter milliliter of extraction buffer [10 
mM Tris·HCI (pH 7.4), 10 mM MgCI2, 30 mM KCI, 0.5% 
Triton X-100, and 0.1 mM dithiothreitol] was added and the 
plates were gently shaken every 5 min for 20 min. They were 
then tilted for 5 min, followed by removal of the cell extract 
with a pasteur pipette. This method produces holes in the 
cellular membrane, releasing the cytoplasmic proteins. Most 
of the cellular membrane and nuclei remain attached to the 
plate. 
The extracts were centrifuged at 1000 X g for 20 min to 
remove residual cellular debris and nuclei. This method of 
extraction gave higher recoveries of HGPRT than freeze-
thawing or homogenization methods. 
Radioimmune-Precipitation. The L + and mutant cell lines 
were grown on 60-mm plates in Eagle's minimal essential 
medium plus 10% fetal calf serum to about 75% confluency. 
The medium was then removed. Plates were washed with 5 
ml of phosphate-buffered saline, and 1.5 ml of minimal es-
sential medium containing [3H]leucine (82 ~Ci/ml) and [3H]_ 
lysine (82 ~Ci/ml) or [35S ]methionine (82 ~Ci/ml) instead of 
the respective nonradioactive amino acids was added. The 
specific activity of the radioactive amino acids ([aH ]Ieucine, 10 
Ci/mmol; [3H]lysine, 9.4 Ci/mmol; [35S]methionine, 20 
Ci/mmol) was adjusted so that the rate of protein synthesis 
was not limited by the concentration of these amino acids. 
The cells were incubated in the radioactive medium for 3 hr 
at 37° followed by three 5-ml washes with phosphate-buffered 
saline at 4°. (Washing with cold buffer was found to more 
effectively remove unincorporated radioactive amino acids.) 
Five milliliters of warm minimal essential medium plus 10% 
fetal calf serum was then added, and incubation continued 
at 37° for the designated times. The cells were again washed 
three times with 5 ml of cold phosphate-buffered saline, and 
extracts were prepared as described above. About 3.5 mg of 
an HGPRT- CRM- cell extract was added to compete with 
radioactively labeled non-HGPRT protein. Antiserum against 
HGPRT (42 J.lg) was then added, followed by incubation at 4° 
for 12 hr. Antibody against rabbit IgG prepared in goat (1.5 
mg) was added, and incubation continued for an additional 
4 hr at 4°. The resulting precipitates were sedimented by 
centrifugation at 1000 X g for 20 min. The supernates were 
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removed. The precipitates were washed with 400 ~I of buffer 
[25 mM Tris (pH 7.5) 3.5 mM MgCI2, 500 mM KCI, and 2% 
Triton X-100] and resedimented by centrifugation at 1000 X 
g for 20 min. This procedure was repeated, followed by a final 
wash with 400 ~I of buffer[50 mM Tris·HCI (pH 7.5) and 7 
mM MgCI2], and the precipitates were sedimented as before. 
The immunoprecipitates were then processed and subjected to 
electrophoresis as described in the next section. 
NaDodSO.Urea Gel Electrophoresis. The stacking gel 
(3.3% aCl:ylamide and 0.08% N,N'-methylene bisacrylamide) 
contained 125 mM Tris· HCI (pH 6.8), 0.1% NaDodS04, and 
6 M urea. The separating gel (11.1% acrylamide and 0.27% 
N,N'-methylene bis-acrylamide) contained 150 mM Tris (pH 
8.7),0.1% NaDodS04, and 6 M urea. The running buffer was 
25 mM Tris base, 192 mM glycine, 0.1% NaDodS04, and 6 M 
urea. The sample-loading buffer contained 50 mM Tris·HCI 
(pH 6.8),1.6% NaDodS04, 5.4 M urea, 18% glycerol, 0.001% 
bromphenol blue, and 5% 2-mercaptoethanol. N,N,N',N"-
Tetramethylethylenediamine and persulfate were adjusted to 
give a 10- to 15-min gelling time. Samples, prepared by im-
munoprecipitation, were dissolved in 100 ~I of sample-loading 
buffer and heated at 100° for 5 min. The sample was loaded 
onto the gel with a Hamilton s)Tinge. The gels (6 X 90 mm) 
were subjected to electrophoresis at a constant current of 3.5 
rnA per gel. The bromphenol blue reached the end of a 9-cm 
gel after about 8 hr. 
All gels were internally calibrated with fluorescein isothio-
cyanate (isomer I)-labeled molecular weight standards. 
The fluorescein isothiocyanate labeling was done by the meth-
ods of Kawamura (19). The positions of the molecular weight 
standards were determined by visual examination under UV 
illumination. The fluorescein isothiocyanate-Iabeled proteins 
were shown to electrophorese with their unlabeled counter-
parts on NaDodS04-urea gels. 
RESULTS 
Detection of Wild-Type and Mutant HGPRT in Cell Ex-
tracts. Antiserum against HGPRT was used to isolate radio-
actively labeled HGPRT molecules from L+ and HGPRT-
mutant cell extracts labeled with [3H]aminoacids. An excess 
of antiserum against HGPRT was allowed to react with the 
extracts overnight, followed by the addition of antibody 
against rabbit IgG prepared in goat to insure complete pre-
cipitation of HGPRT (the specificity of the antiserum against 
HGPRT is described in detail in ref. 17). The radioactively 
labeled immunoprecipitate was then examined by electro-
phoresis on calibrated NaDodSO.urea polyacrylamide gels. 
We have shown in a previous communication that HGPRT is 
composed of subunits with a molecular weight of 27,000 (20). 
The results of representative radioimmunoprecipitations of 
extracts prepared from L+, an HGPRT- CRM+ cell line, and 
an HGPRT- CRM- cell line are illustrated in Fig. 1. The 
CRM activity in the mutant cell lines was determined by the 
standard precipitation-inhibition assay in which CRM is 
detected if it can compete with wild-type HGPRT for sites on 
the antibody and thus displace enzymatic activity into the 
supernate (17). Fig. 1a shows the pattern of radioactivity 
after electrophoresis on N aDodSO.urea polyacrylamide gels 
of the immunoprecipitate from wild-type L cells (L +) labeled 
with [3H ]lysine and [IH ]leucine. A sharp peak of radioactivity 
migrating with a molecular weight of 27,000 is observed. Fig. 
1b is the pattern from an HGPRT- CRl\f+ cell line (M345). 
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FIG. 1. Analysis of HGPRT isolated from L+ and mutant 
(HGPRT-) cell extracts by radioimmune precipitation. The L+ 
and HGPRT- mutants were labeled with radioactive amino 
acids, the cell extracts were prepared, treated with antiserum 
against HGPRT and antibody against rabbit IgG prepared in 
goat, and the immunoprecipitate was processed and subjected to 
electrophoresis on N aDodSO.-urea polyacrylamide gels as 
described in Materials and Methods. Each gel was internally 
standardized with ftuoresceinated myoglobin (MYO), fluores-
ceinnted aldolnse (ALD), nnd bl"Omphenol blue. The ftuore.'1cein-
labeled proteins' were shown to electrophorese with their un-
labeled counterparts on NaDodSO,-urea polyacrylamide gels. 
Panel a shows the pattern of radioactivity after electrophoresis of 
the immunoprecipitate isolated from L + extracts. Panel b shows 
the results of coprecipitation of [3H]leucine- and ['H]lysine-
(Legend continued) -+ 
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FIG. 2. Rate of total protein degradation in the L + and mu-
tant cell lines M345, M343, M398, and M463. Plates (50 mm) of 
the cell lines L+, M345, M343, M398, and M463 were grown to 
75% confiuency. The nonradioactive medium was then removed; 
plates were washed and radioactive medium was added as de-
scribed in Material8 and Meth0d8. The cells were then incubated 
in the presence of radioactive amino acids for 3 hr at 37°. The 
radioactive medium was in turn removed, cells were washed, 
nonradioactive medium was added back, and incubation con-
tinued at 37°. At the designated times, cell extracts were pre-
pared, and a 100pI. aliquot was removed to determine the total 
protein degradation rate in each cell line. The aliquot of cell 
extract was precipitated with 3 ml of 7% trichloroacetic acid in 
the presence of 0.5 mg of carrier bovine serum albumin. The 
precipitate was sedimented by centrifugation at 1000 X g for 15 
min at 2°. The pellet was dissolved in 250 pi. of 0.5 M NaOH to 
hydrolyze aminoacyl-tRN A ester bonds. The protein was re-
prec\pitated with 3 ml of 7% trichloroacetic acid and collected by 
filtration on Whatman GFC fiber filters. The level of radioactive 
protein present in each sample was determined by liquid scintilla-
tion counting in 5 ml of Patterson-Greene scintillation fluid (18). 
e, L+; 0, M345; X, M343; 6, M398; and D, M463. 
As an internal marker, [158]methionine-labeled L+ immuno-
precipitate was added. Both the 'H and liS radioactivity were 
observed to coelectrophorese at 27,000 daltons. Fig. Ic is the 
pattern obtained with an HGPRT-, CRM- cell line. The 
tritium radioactivity peak is absent. These experiments con-
firm genetically that the 27,OOO-dalton peak is the HGPRT 
subunit . 
Degradation of Wild-Type and Mutant HGPRT. For deter-
mination of the rates of degradation of wild-type and mutant 
HGPRT, the cell lines L+, M345, M343, M398, and M463 
were incubated. with medium containing ['H]lysine and 
[8H]leucine followed by removal of the radioactive medium. 
The cells were thoroughly washed with buffer and placed 
in medium containing unlabeled leucine and lysine at 
concentrations 300 times higher than in the radioactive me-
dium. Mter incubation for the indicated. times at 37°, cell 
extracts were prepared and immunoprecipitated. as described. 
labeled IIGPRT- CRM+ cell extract (M345; e) and [D8]-
methionine L+ cell extract (0). The protein ratio of the extracts 
(-S/'H) was 1/20. The experiment in panel c is as in panel b, 
except that a [IH]leucine- and [IH]lysine-labeled HGPRT-
CRM- cell extract was used instead of an HGPRT- CRM+ cell 
extract. The peak of radioactivity corresponds to a molecular 
weight of 27,000. 
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FIG. 3. Rate of degradation of L+ and mutant HGPRT 
molecules. Plates (60 mm) of the cell lines L+, M345, M343, 
M39S, and M463 were grown. Cultures were labeled with radio-
active amino acid, washed, and reincubated for the designated 
times in medium containing an excess of unlabeled amino acids. 
Cell extracts were prepared. An aliquot was removed, and total 
protein breakdown rate was measured (Fig. 2). The L + and mutant 
HGPRT molecules were then isolated from the extracts by im-
munoprecipitation with antiserum against HGPRT and anti-
body against rabbit IgG prepared in goat. The radioactively 
labeled immunoprecipitates were then processed and subjected to 
electrophoresis on calibrated N aDodSO.-urea polyacrylamide 
gels. The level of HGPRT (L+ and mutant) present in the ex-
tract was quantitated by integrating the radioactivity under 
the 27,000-dalton 'peak and normalized to the amount of radio-
activity incorporated when the [3HJaminoacids were removed. 
e, L+; 0, M345; X, M343; .6., M39S; and 0, M463. 
in Materials and Methods. The radioactive immunoprecipitate 
was then examined on calibrated N aDodSOcurea polyacryl-
amide gels. The amourit of wild-type or mutant HGPRT 
present in the cell extracts was quantitated by integrating the 
radioactivity under the 27,OOO-dalton peak. 
In Fig. 2 we illustrate that the removal of radioactive amino 
acids from the cells was effective. We observe the expected 
logarithmic loss of base-stable, trichloroacetic acid-precipit-
able radioactivity as a function of time. Fig. 2 also shows that 
the rate of total protein degradation in the different cell lines 
is the same. 
Fig. 3 demonstrates that the rates of degradation of L + 
HGPRT and the mutant forms of HGPRT are very different. 
The wild-type enzyme is observed to turn over more slowly 
than the average protein in the cell. Mutant .HGPRT from 
M463 is degraded 17.5-fold faster than L+ HGPRT. Fig. 3 
also shows that the chase of radioactive amino acids was effec-
tive in these experiments. One would not expect straight log-
arithmic decay curves if reincorporation of radioactive amino 
acids were a problem. 
The altered rates of degradation of the defective HGPRT 
molecules could be caused either by the structural alterations 
in the mutantHGPRTs, increasing theIr susceptibility to 
proteolysis, or the presence of an unselected second mutation 
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FIG. 4. Extrapolation of the L+and mutant HGPRT break-
down data back to zero time (i.e., the time of addition of radio-
active amino acids). The breakdown data described in Fig. 3, 
after correction for the total amount of [3HJaminoacid incorpora-
tion in the various cell lines, is extrapoiated back to zero time. 
The 3-ht point is the time when the radioactive medium was re-
placed with nonradioactive medium. e, L+; 0, M345; X, M343; 
.6., M39S; and 0, M463. 
that specifically effects HGPRT degradation without affecting 
total protein breakdown. We feel that this second mechanism 
is extremely unlikely since it would require the presence of a 
specific unselected mutation in each of the mutants that we 
have studied (i.e., 43 mutants). 
Levels oj L+ and Mutant HGPRT Present in the Cells. After 
incubation in the presence of [3Hlaminoacids for 3 hr at 37°, 
the various mutant cell lines contain different levels of radio-
actively labeled defective HGPRT molecules, as determined 
by precipitation with an excess of antiserum against HGPRT 
and goat antibody against rabbit IgG serum. The breakdown 
data for HGPRT and the mutants is extrapolated back to zero 
time in Fig. 4. It can be seen that all of the curves extrapolate 
back, within experimental error, to the same point. This 
observation indicates that the rates of synthesis of mutant 
HGPRT in the. various cell lines are equivalent to that of 
L +. Since the overall level of proteolysis is the same in the 
various cell lines, this implies that the different concentrations 
of defective HGPRT molecules are due to the inherent dif-
ferences in their susceptibility to breakdown. 
DISCUSSION 
We mentioned in the introduction that abnormal proteins 
. could arise in cells by a number of different mechanisms. 
Proteins may age by denaturation or by chemical or enzymatic 
modification (~). Errors in transcription and translation 
would also produce defective proteins (7). Diploid cells can 
carry recessive mutations, causing the production of defeCtive 
proteins by the mutated allele. Abnormal proteins could be 
deleterious to the cell as a result of their own cytotoxicity 
or by causing the production of other abnormal proteins. 
As examples of the latter, errors in the DNA replication, 
transcriptional, or protein synthetic machinery of the cell 
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could lead to ever increasing production of defective proteins. 
A simple model of cellular aging postulates just such an 
"error catastrophe" (21, 22). It would be advantageous for 
the cell to be able to selectively degrade abnormal proteins. 
The cell would then be able to maintain a low, stable level of 
errors, preventing premature death. 
To test the hypothesis of selective degradation of abnormal 
proteins, we have examined the rates of proteolysis of HGPRT 
of several missense mutants. The experiments were done in a 
way that would not perturb the cells' physiology, since such 
perturbations could themselves cause increased rates of 
proteolysis. Under the growth conditions used, HGPRT is a 
nonessential enzyme. It represents only about 1/5000 of the 
total soluble protein pool. The loss of HGPRT enzymatic 
activity or a large change in its dcgradation rate should not 
affect the turnover of the total protein pool. 
We have presented evidence in a previous communication 
that these HGPRT- CRM+ mutants are of the missense 
type (17). They were derived by using N-methyl-N'-nitro-N-
nitrosoguanidine mutagenesis followed by selection for re-
sistance of 8-azaguanine and 6-thioguanine (18). These mu-
tants arose at a low frequency «10-8 spontan~ous; about 
10-8 with N-methyl-N'-nitro-N-nitrosoguanidine mutagene-
sis). The mutant proteins electrophorese with L+ HGPRT on 
calibrated NaDodSOcurea polyacrylamide gels. Since the 
subunit molecular weights of the mutant proteins are the same 
as L+ HGPRT, it is unlikely that they are nonsense or dele-
tion mutants. Revertants from each of the HGPRT- CRM+ 
cell lines have been isolated. This provides further evidence 
against the possibility of deletion mutants. Since N -methyl-
N'-nitro-N-nitrosoguanidine was used as the mutagen, and the 
mutant proteins retain immunological crossreactivity, frame-
shift mutations are also unlikely. From this we conclude that 
the HGPRT- CRM+ mutants used in this study are missense 
mutants. 
The rates of degradation of a number of mutant forms of 
HGPRT (and of L + HGPRT) are shown in Fig. 3. The rates of 
total protein breakdown in the mutant and wild-type cell lines 
are the same (see Fig. 2). It can be seen that the defective 
HGPRT molecules are broken down 3- to 17.5-fold faster 
than wild-type enzyme. These studies show that even a small 
change in a protein, such as a missense mutant that still re-
tains its antigenic determinants, is sufficient to cause selective 
degradation. This means that the cellular machinery for pro-
tein degradation is extremely efficient at detecting abnormal 
proteins. A simple model that could explain this selectivity is 
that most proteins have undergone a strong selective pressure 
to attain a configuration resistant to proteolytic breakdown 
(23). For these proteins, almost any change in configuration 
would result in increased sensitivity to proteolysis. There may, 
of course, exist classes of proteins for which a high rate of 
turnover is advantageous to the cell. 
The HGPRT- CRM+ mutants we have used in this study 
all have the same rate of total protein breakdown as the 
parental L + cell line. The rates of synthesis of the CRM are 
also the same as L+. The levels of the mutant HGPRTs in the 
cells are, however, lower than L+ HGPRT because of their 
increased rates of breakdown. This selective proteolysis ap-
pears to be the controlling factor in determining the cellular 
concentration of the abnormal protein. All 43 of the HGPRT -
CRM+ cell lines we have examined have lower levels of CRM 
than L+ has HGPRT. The mutants selected for this study 
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have relatively high levels of CRM to permit an accurate 
determination of their breakdown rates. This means, however, 
that most of the HGPRT- CRM+ mutants that we have iso-
lated probably contain forms of HGPRT that are broken 
down even more rapidly than those reported in these studies. 
We have emphasized proteolytic degradation to accoUnt for 
the rapid loss of altered HGPRT molecules in the mutant cell 
lines. As an alternative mechanism, the mutant proteins 
could have inherently faster intracellular denaturation rates 
with the concomitant loss of antigenic reactivity. Our previous 
studies on the rates of heat denaturation in vitro of the altered 
HGPRT molecules in these mutants do not support this sec-
ond explanation (17). M345 and M343 are much more re-
sistant to heat denaturation than L+ HGPRT (i.e., M345 
and M343 have half-lives of 50 and 125 min at 80°, respec-
tively, compared to 23 min for L+ HGPRT). We have also 
observed no correlation between heat stability in vitro and de-
gradation rates in vivo of the mutant HGPRTs. One would 
anticipate such a correlation if spontaneous denaturation 
were the e"-planation. We conclude, therefore, that mam-
malian cells contain a very sensitive mechanism for selec-
tively degrading abnormal proteins. 
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